Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats

Psychopharmacology

Volumn 167, Issue 1, 2003, Pages 103-111

  Vickers, S P ^a   Webster, L J ^a   Wyatt, A ^a   Dourish, C T ^a   Kennett, G A ^a  

^a Vernalis PLC   (United Kingdom)

Author keywords

CB1 receptors; Chronic; Paired feeding; Rimonabant; SR 141716; Tolerance; Zucker rat

Indexed keywords

CANNABINOID 1 RECEPTOR; PLACEBO; RIMONABANT; SIBUTRAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEEDING BEHAVIOR; FOOD INTAKE; GROOMING; LOCOMOTION; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SCRATCHING; WEIGHT GAIN; YAWNING;

EID: 0038070321     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1384-8     Document Type: Article

References (28)

1. 9-Tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J Pharmacol Exp Ther 278:1290-1295
2. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132:104-106
3. 1 receptor antagonist anorectic efficacy vs adipose tissue mass reduction. Symposium on the cannabinoids, Burlington, Vt., International Cannabinoid Research Society
4. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sci 63:PL113-117
5. 1 receptor antagonist SR 141716A in naive mice. J Neural Transm 107:931-945
6. Devane WA, Dysfarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613
7. Devane WA, Hanus L, Breuer A, Pertwee RG, tevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
8. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jaral Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822-825
9. Foltin RW, Fischmann MW, Byme MF (1988) Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 11:1-14
10. Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodriguez de Fonseca (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612-9617
11. Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 98:3662-3665
12. Heshmati HM, Caplain H, Bellisle F, Mosse M, Fauveau C, Le Fur G (2001) SR141716, a selective cannabinoid CB1 receptor antagonist, reduces hunger, caloric intake, and body weight in overweight or obese men. Obesity Res 9:O69
13. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202
14. 9-THC and other cannabinoids. Pharmacol Biochem Behav 71:155-162
15. Jamshidi N, Taylor DA (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134:1151-1154
16. Kirkham TC, Williams CM (2001) Endogenous cannabinoids and appetite. Nutr Res Rev 14:65-86
17. Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550-557
18. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
19. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90
20. Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MRA, Rodriguez de Fonseca F (1997) Acute administration of the CB1 receptor antagonist SR 141716A induces anxiety-like responses in the rat. NeuroReport 8:491-496
21. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P (1994) SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
22. Rowland NE, Mukherjee M, Robertson K (2001) Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology 159:111-116
23. Ryan DH, Kaiser P, Bray GA (1995) Sibutramine: a novel new agent for obesity treatment. Obesity Res 3:553S-559S
24. Simiand J, Keane M, Keane PE, Soubrie P (1998) SR 141716, a cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9:179-181
25. Vickers SP, Benwell KR, Porter RH, Bickerdike MJ, Kennett GA, Dourish CT (2000) Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol 130:1305-1314
26. Williams CM, Kirkham TC (1999) Anandamide induces overeating: mediation by central cannabinoid receptors. Psychopharmacology 143:315-317
27. 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:341-348
28. 9-THC. Physiol Behav 65:343-346